After decades of unchecked price increases, the three manufacturers controlling 90% of the insulin market implemented $35 monthly copay caps
In addition, although earlier GLP-1 medications have been used safely for decades in people with diabetes, the long-term effects of lifelong use of newer, more potent agonists remain unknown
Exenatide (Byetta) was approved in 2005 and is administered as a subcutaneous injection twice daily, taken within 60 minutes before morning and evening meals
Recently, extracellular matrix derived from mesenchymal stem cells were shown to maintain re-differentiation potential of human chondrocytes ( Conclusion In vitro expanding human chondrocytes to a number that is required by the ACI results in the generation of senescent cells
Finally, it's a complete waste of a premium product
Sign up to the Institute now